- Home
- SYRE vs BRKR Comparison
SYRE vs BRKR Comparison
Compare SYRE & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | BRKR |
|---|---|---|
| Founded | 2013 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 8.6B |
| IPO Year | 2015 | 2000 |
Fundamental Metrics
Financial Performance| Metric | SYRE | BRKR |
|---|---|---|
| Price | $96.64 | $58.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 13 |
| Target Price | ★ $122.53 | $63.83 |
| AVG Volume (30 Days) | 1.1M | ★ 2.4M |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 0.31% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | N/A | $3.48 |
| Revenue Next Year | N/A | $4.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.15 | $32.37 |
| 52 Week High | $110.18 | $68.98 |
Technical Indicators
Market Signals| Indicator | SYRE | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 59.55 |
| Support Level | $93.45 | $53.01 |
| Resistance Level | $105.09 | N/A |
| Average True Range (ATR) | 4.29 | 3.54 |
| MACD | 1.22 | 0.34 |
| Stochastic Oscillator | 93.81 | 64.73 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.